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Abstract 
Background: Clinical trials of the RTS,S malaria vaccine have completed Phase III and the vaccine is on track for 
registration. Before making decisions about implementation, it is essential to prepare the ground for introducing the 
vaccine by assessing awareness and willingness to use malaria vaccines and to provide policy makers with evidence-
based information on the best strategies to engage communities to manage the introduction of malaria vaccine in 
Tanzania.
Methods: In November 2011, as part of a large cross-sectional study of all 23 regions of Tanzania (mainland Tanzania 
and Zanzibar) was conducted during Tanzanian Integrated Measles Campaign (IMC) survey. In this study, the variables 
of interests were awareness and willingness to use a malaria vaccine. The main outcome measure was willingness to 
use a malaria vaccine. Logistic regression was used to examine the influence of predictive factors.
Results: A representative sample of 5502 (out of 6210) women, aged 18 years or older and with children under 
11 months old, was selected to participate, using random sampling probability. Awareness of the forthcoming malaria 
vaccine, 11.8 % of participants in mainland Tanzania responded affirmatively, compared to 3.4 % in Zanzibar (p value 
<0.0001). 94.5 % of all respondents were willing to vaccinate their children against malaria, with a slight difference 
between mainland Tanzania (94.3 %) and Zanzibar (96.8 %) (p value = 0.0167).
Conclusions: Although mothers had low awareness and high willingness to use malaria vaccine, still availability of 
malaria vaccine RTS,S will compliment other existing malaria interventions and it will be implemented through the 
Immunization, Vaccines and Biologicals (IVB) programme (formerly EPI). The information generated from this study 
can aid policy makers in planning and setting priorities for introducing and implementing the malaria vaccine.
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Background
Malaria still remains a significant public health problem 
in sub-Saharan Africa, including Tanzania, accounting 
for 10  % of the burden of disease [1]. Recently, techni-
cal innovations to control malaria have contributed to a 
decline in the malaria burden, but the disease remains 
a significant threat due to persistent enabling environ-
ments, poverty and fragile health systems [1]. Therefore, 
additional strategies are needed to ensure a combina-
tion of interventions that target the various phases of 
the malaria life cycle, including malaria vaccination [2]. 
Vaccines are considered cost-effective interventions to 
reduce and eliminate burden of infectious diseases [3–9].
There are on-going efforts to deliver malaria vaccines 
as a means to achieving elimination of malaria. Malaria 
vaccine RTS,S is the most advanced candidate to undergo 
large scale Phase III evaluation in Africa. It has been 
tested in eight countries with varying degrees of preven-
tion of malaria transmission. The study sites included: 
Nanoro in Burkina Faso; Kintampo and Agogo in 
Ghana; Lambarene in Gabon; Manhica in Mozambique; 
Lilongwe in Malawi; Kilifi, Siaya and Kombewa in Kenya; 
and Bagamoyo and Korogwe in Tanzania [10]. Further-
more, phase II and III clinical trials of RTS,S showed 
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that the vaccine reduced the episodes of malaria among 
young children and infants in malaria endemic areas by 
half [10–13]. Upon completion of the clinical trials, pol-
icy makers will need to make evidence-based decision on 
the best ways to engage communities to facilitate intro-
duction of malaria vaccine in the national health systems 
using Tanzania as a case study. The availability of RTS,S 
will contribute to a multi-intervention approach to con-
trolling malaria that currently uses long-lasting insec-
ticide-treated nets (LLITNs), insecticide-treated nets 
(ITNs), indoor residual spraying (IRS), and other means 
of disease reduction and effective drug treatment [10].
Studies on vaccine adherence interventions and accept-
ance of vaccines recommended use of strategies that will 
enhance positive community knowledge and perceptions 
on vaccine effectiveness [14, 15]. Effectiveness of vac-
cines rely on both clinical efficacy and on a community’s 
perceptions [8]. During vaccine promotion lack of com-
munity support due to poor knowledge and perceptions 
resulted into poor community uptake while others reject 
vaccines [16]. In such contexts aligning stakeholders is an 
important input as was suggested in the network analy-
sis to examine decision-making space in Nigeria [17, 18]. 
Another similar experiences was the community refec-
tion of deworming programme in Ghana [19].
Whereas Tanzania shares similar social cultural and 
economic contexts to those countries mentioned above 
there is a high likelihood that new or even current vac-
cines can be similarly rejected and thus undermining 
efforts to adopt new technologies to address the high 
burden of disease. Therefore, it is crucial that community 
awareness of and willingness to use the malaria vaccine 
as well as community perceptions of its likely impact are 
well understood and used to highlight any community-
based issues that need to be considered during policy 
deliberation and intervention planning [20]. The policy 
recommendations for introducing malaria vaccine RTS,S 
would be implemented in countries through the World 
Health Organization’s Immunization, Vaccines and Bio-
logicals (IVB) (formerly the Expanded Programme on 
Immunization—EPI) [21]. Based on this, the case study 
was initiated with the following objective: to describe 
and analyse the Tanzanian population’s awareness and 
willingness to use malaria vaccines and to provide poli-
cymakers with evidence-based information on the best 
strategies to engage communities to manage the intro-
duction of new vaccine and in this case malaria vaccine 
in Tanzania.
Methods
Study design and setting
The study was part of a large cross-sectional study cov-
ering all 23 regions of both Tanzania mainland and 
Zanzibar whose aim was to evaluate the success of Tan-
zanian Integrated Measles Campaign conducted during 
November 2011.
Study sample size and sampling procedure
It was anticipated that the overall EPI coverage in the sur-
veyed regions was estimated to be 85 % (the desired pre-
cision is ±5 % with 95 % confidence). Thirty clusters were 
sampled [22], and 9 women with children 0–11 months 
old per cluster were identified. A total of 6210 women 
with children 0–11  months old were recruited. For the 
purpose of this analysis, only 5502 women met the eli-
gibility criteria and were included in the final analy-
sis (n  =  5502). The sampling procedure was based on 
30-by-9 method and simple random sampling applied. 
The 30-by-9 method was a two-stage cluster sample. In 
the first stage, 30 clusters (corresponding to enumeration 
areas—EAs) were sampled by a probability proportion 
to size (PPS) strategy using the CSurvey software. In the 
second stage of sampling, nine eligible women with chil-
dren 0–11 months old were selected within each EA.
Not all of the first nine households visited had an eligi-
ble child; therefore, more than nine households may have 
been visited. Similarly, fewer than nine households may 
have been selected if there was more than one eligible 
child per household. A sample of 30 enumeration clusters 
(villages) per region was surveyed; the minimum sam-
ple size was 270 mothers in each region. In each region, 
30 clusters were visited and in each cluster, nine moth-
ers with a child aged 0–11  months old were randomly 
selected and visited.
The following steps were followed:
 – Within the regions, 30 EAs were selected using the PPS 
strategy.
  – In each EA, nine eligible children were selected from 
households as follows:
  – Go to the “centre” of the EA.
  – Throw a pen to choose a random direction.
  – Walk in that direction to identify the first household.
  – Visit the first selected household and start to recruit 
the eligible children.
  – After the first household visited, data collector moved 
to the “next household”, which was defined as the one 
whose front door was the closest to the just one visited.
  – This process was continued until all nine eligible chil-
dren were found/reached.
Primary outcome and explanatory variables
The primary outcome variable was willingness to use a 
malaria vaccine; mothers were asked if they would like 
their children to receive malaria vaccine. The follow-
ing explanatory variables of willingness to use a malaria 
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vaccine were investigated: (1) awareness of the forth-
coming malaria vaccine; mothers were asked if they ever 
heard about malaria vaccine. (2) Knowledge of the health 
benefits of vaccinating under-five children, mothers were 
assessed if they know malaria vaccine can prevent chil-
dren from getting malaria, reduced disease infection and 
death or enhance good health. (3) Mothers to accept the 
mode of administering the malaria vaccine (require 2-3 
jabs to receive full benefit). (4) Mothers to agree pro-
posed schedule of given malaria vaccine at the same 
health facility and at the same time as other childhood 
vaccines. Other explanatory variables were ITNs owner-
ship, EPI and measles vaccination.
Data management and analysis
Data were double entered from data collection forms into 
a computer data file using Data Management System for 
Clinical Trials Software (DMSys) (Sigma soft Interna-
tional, Cincinnati, USA) [23]. Data were reviewed after 
the initial data entry to check for out-of-range responses, 
missing values, or inconsistent skip patterns; the original 
data collection sheets were reviewed to resolve any dis-
crepancies or problems.
The data were analysed using STATA 11 standard edition 
software (StataCorp, TX, USA). The data were summarized 
using frequency tables and cross tabulation. Cross tabula-
tion was done to assess the association between knowledge 
of the benefits of under-five vaccination and awareness of 
the forthcoming malaria vaccine; and between knowledge 
of the benefits of under-five vaccination and willingness to 
use a malaria vaccine. Categorical data was reported with 
numbers and percentage and their associated p values. 
Cross tabulation and Chi square was used to test associa-
tion between variables in a two by two table. Fisher’s exact 
test was used to compare proportions in two by two tables 
where expected value in a cell was less than five. Univariate 
logistic regression was used to determine the magnitude of 
association for each exposure variable and outcome varia-
ble. Variables that showed association at a 0.25 significance 
level in univariate analysis were considered as candidates 
for the multivariate analysis. Multiple logistic regressions 
were used to determine the association between willing-
ness and the primary exposure variable, while controlling 
for possible confounders. P values of less than or equal to 
0.05 were considered significant.
Ethical approval
The study was part of the Tanzanian Integrated Measles 
Campaign (IMC) survey in November 2011 and received 
ethical approval from the Institutional Review Boards of 
Ifakara Health Institute. Written informed consent was 
obtained from all participants prior to the start of the 
interviews.
Results
Data was collected using structured questionnaires 
(Additional file 1) that assessed mothers of eligible chil-
dren on awareness and willingness to use a malaria vac-
cine, health benefits of vaccinating under-five children, 
mode of administering malaria vaccine and its pro-
posed schedule. The study involved 5502 mothers whom 
were asked about awareness of the forthcoming malaria 
vaccine, 11.8  % of participants in mainland Tanzania 
responded affirmatively, compared to 3.4  % in Zanzibar 
(Additional file 2); (p value <0.0001) (Table 1). 94.5 % of 
respondents were willing to take their children to get 
malaria vaccination, with a slight difference between 
mainland Tanzania (94.3 %) and Zanzibar (96.8 %) (Addi-
tional file 2); (p value = 0.0167) (Table 1).
Most (88.4  %) of the respondents reported know-
ing the benefits of vaccinating children under-five, with 
88.5  %in mainland Tanzania and 87.9  % in Zanzibar 
(Additional file  3). The difference was not statistically 
significant (p value  =  0.6917) (Table  1). The majority 
(81.3 %) of respondents reported accepting the mode of 
administering the malaria vaccine (2-3 jabs), with a high 
proportion (82.6  %) of acceptability among mainland 
Tanzanians than in Zanzibar (68.8 %) (Additional file 3); 
(p value <0.0001) (Table  1). Most (86.7  %) respondents 
would send their children for malaria vaccine according 
to the proposed schedule, with 86.7 % of respondents in 
mainland Tanzania and 87.1 % of respondents in Zanzi-
bar (Additional file 3); the difference was not statistically 
significant (p value = 0.7816) (Table 1).
The proportion of respondents with knowledge of 
malaria prevention, mainly ITN ownership, was 71.7  % 
overall, and slightly higher in Zanzibar (73.1 %) as com-
pared to mainland Tanzania (71.5 %); the difference was 
not significant (p value  =  0.4380, Table  1). Respond-
ents whose children received EPI vaccines were 84  % 
overall and significantly (90.8  %) in Zanzibar compared 
to mainland Tanzania (83.8  %). However, respondents 
Table 1 Comparison of  perceived indicators of  malaria 
vaccine between Zanzibar and Mainland, Tanzania
Perceived indicator Zanzibar Mainland p value
Willingness 96.8 (511/528) 94.3 (4690/4974) 0.0167
Awareness 3.4 (18/528) 11.8 (589/4974) <0.0001
Benefit 87.9 (464/528) 88.5 (4400/4974) 0.6917
Delivery mode 68.8 (363/528) 82.6 (4110/4974) <0.0001
Proposed schedule 87.1 (460/528) 86.7 (4312/4974) 0.7816
ITN ownership 73.1 (386/528) 71.5 (3557/4974) 0.4380
Received EPI vaccines 90.8 (1316/1449) 83.8 (3353/4001) <0.0001
Received measles vac-
cines
72.3 (1109/1534) 72.2 (5412/7498) 0.9378
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whose children received EPI vaccines were statistically 
significant (p value <0.0001, Table 1). Overall, 72.2 % of 
respondents whose children received measles vaccines, 
respondents whose children received measles vaccines 
were similar between Zanzibar (72.3  %) and mainland 
Tanzania (72.2 %). The difference was not statistically sig-
nificant (p value = 0.9378, Table 1).
Discussion
Understanding community perceptions can help to iden-
tify issues to guide policy decisions for introducing the 
malaria vaccine. These findings are similar to studies 
documenting the need for early planning for new inter-
ventions, essential for policy decision making and rel-
evant information can speed up the efforts to facilitate its 
implementation [20]. Understanding community percep-
tions of a malaria vaccine also helps to inform country 
programme managers responsible for National Malaria 
Control Programme (NMCP) and EPI/IVB priority set-
ting and planning.
The low (11  %) level of awareness of the forthcoming 
malaria vaccine and high (94.5  %) willingness to use a 
malaria vaccine were similar to those found by Colon-
Lopez and others for HPV vaccination in Puerto Rico 
[24], which also indicated low (28.3  %) level of aware-
ness of and high (76.9  %) willingness to use HPV vac-
cines. Both findings come from settings where none of 
the study participants had been vaccinated. Despite low 
awareness about vaccine, mothers are still willing to vac-
cinate their children. This finding suggests that knowl-
edge does not lead to achievement of vaccine coverage. 
This is quite consistent in many low-income countries. 
Thus, creating awareness of the malaria vaccine would 
be effective; although, currently understanding among 
respondents is low because the malaria vaccine is new 
and most people had not yet learned about it. Informing 
women about the malaria vaccine would likely increase 
women’s interest in their willingness to use a malaria vac-
cine. Creating awareness of malaria vaccine could reveal 
policy-related issues that, once addressed, could facilitate 
delivery of malaria interventions [9] and child vaccina-
tions [25].
Willingness to use a malaria vaccine was compared 
to the knowledge of the benefits of vaccinating children 
under-five. This finding is consistent with others’ findings 
in Kenya and Ghana that showed wide spread knowl-
edge of childhood vaccinations [12]; in Ghana, over 90 % 
of respondents understood that the malaria vaccine had 
benefits related to child vaccinations [12, 16, 25, 26]. 
Contrary to the study conducted when malaria vaccine 
efficacy results were not yet available, the level of will-
ingness to use a malaria vaccine differed when respond-
ents considered low efficacy results compared to other 
childhood vaccines [16, 27]. Knowledge of existing rou-
tine immunization schedules and benefits increased the 
level of willingness to use a malaria vaccine. The struc-
ture of the EPI programme in Tanzania is widely spread 
and accessible to the majority of Tanzanian women. As 
the malaria vaccine is expected to be delivered through 
the EPI programme, women would expect the vaccine’s 
benefits to be in line with those of other routine vaccina-
tions. Therefore, informing women about the benefits of 
vaccinating children under-five is likely to increase wom-
en’s interest in the forthcoming malaria vaccine and their 
willingness to use it.
High acceptance of the mode of administering a 
malaria vaccine (2-3 jabs) according to the proposed 
schedule was similar to findings by Febir and others who 
showed that respondents were willing to receive vac-
cines in the form of injections, as most understood that 
“vaccines are injections given to children in their child-
hood to prevent occurrences of diseases” [16]. Contrary 
to Parvez and others, immunization injections were 
perceived to be painful procedures [28]. The injection 
method becomes a challenge when increasing numbers 
of injections as women become less willing to take their 
children for malaria vaccination. After the end of rou-
tine vaccination, parents might not take their children for 
additional vaccinations for a variety of reasons, including 
mothers’ competing priorities. Immunization clinics at 
health facilities and in informal areas (mobile clinics) can 
be good avenues for informing women about the malaria 
vaccine and for scheduling children for vaccination.
The strengths of the study include: larger sample size, 
representative sampling and combining data on aware-
ness of the forthcoming malaria vaccine, willingness to 
use a malaria vaccine, knowledge of the benefits of vac-
cinating children under five, acceptability of the mode 
of administering the vaccine according to the proposed 
schedule, ITN ownership, and knowledge of EPI and 
measles vaccinations. The study had a number of limita-
tions, including lack of demographic data and difficulty 
in determining acceptance of a malaria vaccine that is not 
yet available. It is likely that there are other reasons not 
covered by this study that account for some women’s lack 
of awareness of a forthcoming malaria vaccine and their 
unwillingness to use a malaria vaccine. For example, the 
vaccine may be accepted by the parents but still they do 
not take their children for vaccination due to distance, 
competing maternal priorities and lack of time.
Conclusions and recommendations
Although mothers were highly unaware of a forthcoming 
malaria vaccine, they were very willing to use a malaria 
vaccine. Identifying regions with low awareness of 
malaria vaccine such as Iringa, Dar Es Salaam, Dodoma, 
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Kagera, Kilimanjaro, Mbeya and Tanga would allow 
appropriate advocacy strategies to be planned and com-
munication strategies to be developed before introducing 
the malaria vaccine in Tanzania. Malaria vaccine RTS,S 
will complement existing malaria interventions and be 
implemented through the IVB programme. The informa-
tion generated by this study can aid policy makers as they 
plan and set priorities for introducing and implementing 
the malaria vaccine.
It is recommended that awareness of a potential 
malaria vaccine be created in the entire Tanzanian com-
munity, specifically among mothers who should be 
informed of both the benefits related to child vaccination 
and of the malaria vaccine. This could be accomplished 
by disseminating information to enhance maternal readi-
ness for adopting malaria vaccination.
Abbreviations
EPI: Expanded Programme on Immunization; IMC: integrated measles 
campaign; IVB: immunization, vaccines and biologicals; IRS: indoor residual 
spraying; ITN: insecticide-treated nets; LLITNs: long-lasting insecticide-treated 
nets; TDHS: Tanzania Demographic and Health Survey; WHO: World Health 
Organization.
Authors’ contributions
IR and SA were involved in the study design, responsible for the design of data 
collection tools, and supervision of data collection, management and analysis. 
IR and AMA performed the statistical analyses and contributed to the data 
analysis and interpretation of results. IR drafted the initial paper with extensive 
review from MT SA IS HM and MT reviewed the manuscripts. All authors read 
and approved the final manuscript.
Author details
1 Swiss Tropical and Public health Institute, Socinstrasse 57, Postfach, 
4002 Basel, Switzerland. 2 University of Basel, Basel, Switzerland. 3 Ifakara Health 
Institute (IHI), P.O. Box 78373, Dar Es Salaam, Tanzania. 4 Muhimbili University 
of Health and Allied Science (MUHAS), P.O. Box 65015, Dar Es Salaam, Tanzania. 
5 Commision for Science and Technology (COSTEC), P.O. Box 4302, Dar Es 
Salaam, Tanzania. 
Additional files
Additional file 1. Tool used to collect information on women’s behav-
ioural aspects related to vaccine and malaria Vaccine. The data provided 
used for analysis of study on “Assessment of parental perception of malaria 
vaccine in Tanzania: A Case Study”.
Additional file 2. Percentage distribution of perceived awareness and 
willing to use malaria vaccine. The data provided represent the statistical 
analysis of awareness and willing to use malaria vaccine. Willingness to 
use malaria vaccine was higher in both Zanzibar and Tanzania mainland, 
however, awareness of malaria vaccine was low in the regions, with Zanzi-
bar had the lowest understanding of awareness of malaria vaccine.
Additional file 3. Percentage distribution of perceived benefits, mode 
of administering malaria vaccine and acceptance of proposed schedule. 
The data provided represent the statistical analysis of benefits, mode of 
administering malaria vaccine and acceptance of proposed schedule.  
Majority of women in both Zanzibar and Tanzania mainland understand 
the benefits of vaccine and they are ready to send their children for 
vaccination on any proposed schedule. However, women from Tanzania 
mainland accept the mode of administration (2-3 jabs) more than women 
in Zanzibar.
Acknowledgements
The team acknowledges the communities who willingly participated in this 
study. We wish to extend our gratitude to the field data collectors, study 
supervisors, data entry clerks, data managers and all Ifakara Health Institute 
staffs who contributed in diverse ways towards the success of this study. 
Special thanks go to Dr Christopher Kamugisha and the WHO country office 
for organizing implementation of the IMC survey, which facilitated data col-
lection, and Dr Ba Nguz Antoinette and PATH Malaria Vaccine Initiative (MVI) 
for funds for data set and managing this study. We also acknowledge the 
contribution of Abdallah Mkopi to the data set and management.
Compliance with ethical guidelines
Competing interests
The authors declare that they have no competing interests.
Received: 24 February 2015   Accepted: 2 September 2015
References
 1. WHO. World malaria report 2013. Geneva: World Health 
Organization; 2014. http://www.who.int/malaria/publications/
world_malaria_report_2013/en/.
 2. Graves P, Gelband H. Vaccines for preventing malaria (blood-stage). 
Cochrane Database Syst Rev. 2006;4:CD006199.
 3. Orenstein WA, Hinman AR. The immunization system in the United 
States—the role of school immunization laws. Vaccine. 1999;17(Suppl 
3):S19–24.
 4. Batt K, Fox-Rushby JA, Castillo-Riquelme M. The costs, effects and cost-
effectiveness of strategies to increase coverage of routine immunizations 
in low- and middle-income countries: systematic review of the grey 
literature. Bull World Health Organ. 2004;82:689–96.
 5. De Timóteo Mavimbe JC, Muquingue HN, Braa J, Bjune J. Immunization 
coverage in Mozambique: from concepts to decision-making. Health 
Policy. 2006;79:92–100.
 6. Larson HJ, Cooper LZ, Eskola J, Katz SL, Ratzan S. Addressing the vaccine 
confidence gap. Lancet. 2011;378:526–35.
 7. Bloom DE. The value of vaccination. Adv Exp Med Biol. 2011;697:1–8.
 8. Murele B, Vaz R, Gasasira A, Mkanda P, Erbeto T, Okeibunor J. Vaccine 
perception among acceptors and non-acceptors in Sokoto State, Nigeria. 
Vaccine. 2014;32:3323–7.
 9. Burchett HED, Mounier-Jack S, Griffiths UK, Biellik R, Ongolo-Zogo P, 
Chavez E, et al. New vaccine adoption: qualitative study of national 
decision-making processes in seven low- and middle-income countries. 
Health Policy Plan. 2012;27(Suppl 2):ii5–16.
 10. RTS,S Clinical Trials Partnership. Efficacy and safety of the RTS,S/AS01 
malaria vaccine during 18 months after vaccination: a phase 3 rand-
omized, controlled trial in children and young infants at 11 African sites. 
PLoS Med. 2014;11:e1001685.
 11. Abdulla S, Oberholzer R, Juma O, Kubhoja S, Machera F, Membi C, et al. 
Safety and immunogenicity of RTS, S/AS02D malaria vaccine in infants. N 
Engl J Med. 2008;359:2533–44.
 12. Ojakaa DI, Ofware P, Machira YW, Yamo E, Collymore Y, Ba-Nguz A, et al. 
Community perceptions of malaria and vaccines in the South Coast and 
Busia regions of Kenya. Malar J. 2011;10:147.
 13. RTS,S Clinical Trials Partnership, Agnandji ST, Lell B, Fernandes JF, Abossolo 
BP, Methogo BG, et al. A phase 3 trial of RTS,S/AS01 malaria Vaccine in 
African infants. N Engl J Med. 2012;367:2284–95.
 14. Nuño M, Chowell G, Gumel AB. Assessing the role of basic control meas-
ures, antivirals and vaccine in curtailing pandemic influenza: scenarios for 
the US, UK and the Netherlands. J R Soc Interface. 2007;4:505–21.
 15. Vardavas R, Breban R, Blower S. Can influenza epidemics be prevented by 
voluntary vaccination? PLoS Comput Biol. 2007;3:e85.
 16. Febir LG, Asante KP, Dzorgbo D-BS, Senah KA, Letsa TS, Owusu-Agyei S. 
Community perceptions of a malaria vaccine in the Kintampo districts of 
Ghana. Malar J. 2013;12:156
Page 6 of 6Romore et al. Malar J  (2015) 14:355 
 17. Wonodi CB, Privor-Dumm L, Aina M, Pate AM, Reis R, Gadhoke P, et al. 
Using social network analysis to examine the decision-making process 
on new vaccine introduction in Nigeria. Health Policy Plan. 2012;27(Suppl 
2):ii27–ii38.
 18. Yahya M. Polio vaccines—“no thank you!” barriers to polio eradication in 
Northern Nigeria. Afr Aff. 2007;106:185–204.
 19. Dodoo A, Adjei S, Couper M, Hugman B, Edwards R. When rumours derail 
a mass deworming exercise. Lancet. 2007;370:465–6.
 20. Brooks A, Ba-Nguz A. Country planning for health interventions under 
development: lessons from the malaria vaccine decision-making frame-
work and implications for other new interventions. Health Policy Plan. 
2012;27(Suppl 2):ii50–ii61.
 21. D’Souza BJ, Newman RD. Strengthening the policy setting process for 
global malaria control and elimination. Malar J. 2012;11:28.
 22. World Health Organization. Dept. of Immunization, Vaccines and Biologi-
cals: Immunization coverage cluster survey: reference manual. Geneva: 
World Health Organization; 2005. Available from://apps.who.int//iris/
handle/10665/69087.
 23. Sigmasoft International [cited 2014 Oct 16]. http://www.sigmasoftintl.
com/products.asp.
 24. Colón-López V, Del Toro-Mejías LM, Ortiz AP, Tortolero-Luna G, Palef-
sky JM. HPV awareness and willingness to HPV vaccination among 
high-risk men attending an STI clinic in Puerto Rico. P R Health Sci J. 
2012;31:227–31.
 25. Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated 
with parental acceptance of human papillomavirus vaccines: a rand-
omized intervention study of written information about HPV. Pediatrics. 
2006;117:1486–93.
 26. Bingham A, Gaspar F, Lancaster K, Conjera J, Collymore Y, Ba-Nguz A. 
Community perceptions of malaria and vaccines in two districts of 
Mozambique. Malar J. 2012;11:394.
 27. Olotu A, Fegan G, Wambua J, Nyangweso G, Awuondo KO, Leach A, 
et al. Four-year efficacy of RTS, S/AS01E and its interaction with malaria 
exposure. N Engl J Med. 2013;368:1111–20.
 28. Parvez E, Stinson J, Boon H, Goldman J, Shah V, Taddio A. Mothers’ beliefs 
about analgesia during childhood immunization. Paediatr Child Health. 
2010;15:289–93.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
